J9120 Dactinomycin injection
Also known as: dactinomycin, Cosmegen
Intravenous injection of dactinomycin, an antibiotic chemotherapy agent that intercalates DNA.
In Plain Language
DNA-damaging antibiotic cancer drug; RNA synthesis inhibitor
Clinical Context
Used for Wilms tumor, Ewing sarcoma, gestational trophoblastic disease, and other pediatric cancers.
RVU Information
CPT J9120 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J9120?
CPT J9120 (Dactinomycin injection) is a J Codes (Drugs) code. Intravenous injection of dactinomycin, an antibiotic chemotherapy agent that intercalates DNA.
How is J9120 administered?
CPT J9120 is administered by a healthcare provider, typically via injection or infusion. Used for Wilms tumor, Ewing sarcoma, gestational trophoblastic disease, and other pediatric cancers. It is used by Pediatric Oncology, Medical Oncology.
When is CPT J9120 used?
Used for Wilms tumor, Ewing sarcoma, gestational trophoblastic disease, and other pediatric cancers.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.